文獻(xiàn)資料
聯(lián)系我們
浙江果源康品生物科技有限公司
電話：0570－8788056
傳真：0570－8788381
地址：浙江省衢州市東港經(jīng)濟(jì)開發(fā)區(qū)
東港4路2號
- 改性柑橘果膠MCP激活T輔助/誘導(dǎo)細(xì)胞，毒性T-細(xì)胞，B細(xì)胞，自然吞噬（NK）細(xì)胞與誘導(dǎo)的自然殺傷細(xì)胞對抗K562慢性髓系白血病細(xì)胞
- 發(fā)布時間： 2019/3/13 點(diǎn)擊次數(shù)：3550
-
改性柑橘果膠MCP激活T輔助/誘導(dǎo)細(xì)胞，毒性T-細(xì)胞，B細(xì)胞，自然吞噬（NK）細(xì)胞與誘導(dǎo)的自然殺傷細(xì)胞對抗K562慢性髓系白血病細(xì)胞
Cheppail Ramachandran, Barry J Wilk, Arland Hotchkiss, Hoa Chau, Isaac Eliaz and Steven J Melnick
《BMC補(bǔ)充與替代醫(yī)學(xué)》2011，11:59
摘要
背景：改性柑橘果膠（MCP）能被人體有效的吸收利用，具有顯著的抗癌效果。本文對于MCP激活人血淋巴細(xì)胞亞群如T、B和NK細(xì)胞活性的效果進(jìn)行了驗(yàn)證。
方法：經(jīng)MCP處理的人血樣品和特定抗體混合進(jìn)行培養(yǎng)，采用三色流式細(xì)胞技術(shù)進(jìn)行分析。分離的正常淋巴細(xì)胞與不同濃度的MCP混合，以驗(yàn)證激活后NK細(xì)胞的活性。PKH26標(biāo)記的相對期K562白血病細(xì)胞與淋巴細(xì)胞混合培養(yǎng)4小時。上述的混合物用FITC標(biāo)記的活化型Caspase3抗體進(jìn)行染色，用二色流式細(xì)胞技術(shù)進(jìn)行分析。對于PKH26和FITC呈現(xiàn)陽性的K562細(xì)胞作為NK細(xì)胞誘導(dǎo)死亡的細(xì)胞進(jìn)行計數(shù)。用高效陰離子交換色譜-脈沖安培檢測法分析MCP的單糖分析。
結(jié)果：MCP對于細(xì)胞毒性T細(xì)胞和B細(xì)胞呈現(xiàn)劑量依賴性激活，而對于NK細(xì)胞呈現(xiàn)顯著的劑量依賴性激活效應(yīng)。MCP激活的NK細(xì)胞能有效殺傷癌細(xì)胞。對于MCP成分分析表明，MCP由含有4,5-不飽和非還原性端的寡聚半乳糖醛酸組成。
結(jié)論：MCP對于人血細(xì)胞呈現(xiàn)免疫調(diào)節(jié)的功能，包括激活NK細(xì)胞對抗K562白血病細(xì)胞。不飽和性寡聚半乳糖醛酸可能是MCP中免疫調(diào)節(jié)主要成分。
Activation of Human T-Helper/Inducer Cell, T-Cytotoxic Cell, B-Cell, and Natural Killer (NK)-Cells and induction of Natural Killer Cell Activity against K562 Chronic Myeloid Leukemia Cells with Modified Citrus Pectin
Cheppail Ramachandran, Barry J Wilk, Arland Hotchkiss, Hoa Chau, Isaac Eliaz and Steven J Melnick
MC Complementary and Alternative Medicine 2011,11:59
Abstract
Background:Modified citrus pectin (MCP) is known for its anti-cancer effects and its ability to be absorbed and circulated in the human body. In this report we tested the ability of MCP to induce the activation of human blood lymphocyte subsets like T, B and NK-cells.
Methods:MCP treated human blood samples were incubated with specific antibody combinations and analyzed in a flow cytometer using a 3-color protocol. To test functionality of the activated NK-cells, isolated normal lymphocytes were treated with increasing concentrations of MCP. Log-phase PKH26-labeled K562 leukemic cells were added to the lymphocytes and incubated for 4 h. The mixture was stained with FITC-labeled active form of caspase 3 antibody and analyzed by a 2-color flow cytometry protocol. The percentage of K562 cells positive for PKH26 and FITC were calculated as the dead cells induced by NK-cells. Monosaccharide analysis of the MCP was
performed by high-performance anion-exchange chromatography with pulse amperometric detection (HPAECPAD).
Results:MCP activated T-cytotoxic cells and B-cell in a dose-dependent manner, and induced significant dosedependent activation of NK-cells. MCP-activated NK-cells demonstrated functionality in inducing cancer cell death. MCP consisted of oligogalacturonic acids with some containing 4,5-unsaturated non-reducing ends.
Conclusions:MCP has immunostimulatory properties in human blood samples, including the activation of functional NK cells against K562 leukemic cells in culture. Unsaturated oligogalacturonic acids appear to be the immunostimulatory carbohydrates in MCP.
- 上一篇： 改性果膠成分的生物學(xué)活性
下一篇：MCP、血管內(nèi)皮抑素抑制結(jié)腸癌肝轉(zhuǎn)移的作用研究 - 返回新聞列表
